These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7745686)

  • 1. Reduced glycosylation of human cell lines increases susceptibility to CD4-independent infection by human immunodeficiency virus type 2 (LAV-2/B).
    Talbot SJ; Weiss RA; Schulz TF
    J Virol; 1995 Jun; 69(6):3399-406. PubMed ID: 7745686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: the role of the N-terminal domain of CXCR-4 in fusion and entry.
    Potempa S; Picard L; Reeves JD; Wilkinson D; Weiss RA; Talbot SJ
    J Virol; 1997 Jun; 71(6):4419-24. PubMed ID: 9151832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages.
    McKnight A; Clapham PR; Weiss RA
    Virology; 1994 May; 201(1):8-18. PubMed ID: 8178492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of susceptibility and cell surface receptor for the B-lymphotropic papovavirus by N glycosylation.
    Keppler OT; Herrmann M; Oppenländer M; Meschede W; Pawlita M
    J Virol; 1994 Nov; 68(11):6933-9. PubMed ID: 7933074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).
    Montefiori DC; Stewart K; Ahearn JM; Zhou J; Zhou J
    J Virol; 1993 May; 67(5):2699-706. PubMed ID: 8474169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus.
    Clapham PR; Blanc D; Weiss RA
    Virology; 1991 Apr; 181(2):703-15. PubMed ID: 1673040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
    Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
    J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
    Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
    J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is CD4 sufficient for HIV entry? Cell surface molecules involved in HIV infection.
    Clapham P; McKnight A; Simmons G; Weiss R
    Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):67-73. PubMed ID: 7904349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.
    Ashorn PA; Berger EA; Moss B
    J Virol; 1990 May; 64(5):2149-56. PubMed ID: 2109100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V3 loop-derived peptide SPC3 inhibits infection of CD4- and galactosylceramide- cells by LAV-2/B.
    Moulard M; Mabrouk K; Martin I; Van Rietschoten J; Rochat H; Sabatier JM
    J Pept Res; 1999 Jun; 53(6):647-55. PubMed ID: 10408339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 infectivity of human carcinoma cell lines lacking CD4 receptors.
    Brichacek B; Derderian C; Chermann JC; Hirsch I
    Cancer Lett; 1992 Mar; 63(1):23-31. PubMed ID: 1313332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding.
    Li Y; Luo L; Rasool N; Kang CY
    J Virol; 1993 Jan; 67(1):584-8. PubMed ID: 8416385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.
    Litwin V; Nagashima KA; Ryder AM; Chang CH; Carver JM; Olson WC; Alizon M; Hasel KW; Maddon PJ; Allaway GP
    J Virol; 1996 Sep; 70(9):6437-41. PubMed ID: 8709277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4.
    Clapham PR; McKnight A; Weiss RA
    J Virol; 1992 Jun; 66(6):3531-7. PubMed ID: 1583722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.
    Alkhatib G; Broder CC; Berger EA
    J Virol; 1996 Aug; 70(8):5487-94. PubMed ID: 8764060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection.
    Speck RF; Penn ML; Wimmer J; Esser U; Hague BF; Kindt TJ; Atchison RE; Goldsmith MA
    J Virol; 1998 Jul; 72(7):5728-34. PubMed ID: 9621031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD4 endocytosis in human immunodeficiency virus infection.
    Pelchen-Matthews A; Clapham P; Marsh M
    J Virol; 1995 Dec; 69(12):8164-8. PubMed ID: 7494343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2.
    Dragic T; Alizon M
    J Virol; 1993 Apr; 67(4):2355-9. PubMed ID: 8095307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
    Pal R; Hoke GM; Sarngadharan MG
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.